Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LMWH vs Conventional Method in Isolated Oligohydramnios
NCT07907731Phase 4Recruiting
- Sponsor
- PAEC General Hospital
- Start
- Oct 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
A Phase 4 trial of enoxaparin in Oligohydramnios (Oligo), sponsored by PAEC General Hospital. Started Oct 2026; status: recruiting.
02
Drugs
enoxaparin
03
Conditions
Oligohydramnios (Oligo)
Beyond the preview
Go deeper on NCT07907731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07907731.